Status:
NOT_YET_RECRUITING
Diagnostic Values of Galectin-3, Soluble ST2 and BNP in Predicting the Clinical Outcome of ST-Segment Elevation Myocardial Infarction Patients
Lead Sponsor:
Assiut University
Conditions:
ST Elevation Myocardial Infarction
HF - Heart Failure
Eligibility:
All Genders
18+ years
Brief Summary
An acute ST-elevation myocardial infarction occurs due to occlusion of one or more coronary arteries, causing transmural myocardial ischemia which in turn results in myocardial injury or necrosis. Acu...
Eligibility Criteria
Inclusion
- Age ≥ 18 years.
- Hospital admission due to first-time STEMI treated with pPCI.
Exclusion
- History of previous acute coronary syndrome, Previously diagnosed HF or asymptomatic LV dysfunction with LVEF \<50% or previously diagnosed significant valvular disease or any other previously diagnosed structural heart disease Severe renal dysfunction, Severe liver disease, Chronic inflammatory disease, Current neoplastic disease
Key Trial Info
Start Date :
March 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2026
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT05246215
Start Date
March 1 2022
End Date
March 1 2026
Last Update
February 18 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.